[{"Assets_0_Q3_USD":480642000.0,"CommonStockSharesOutstanding_0_Q3_shares":46159652.0,"EarningsPerShareBasic_1_Q3_USD":0.05,"EarningsPerShareBasic_3_Q3_USD":-0.16,"EarningsPerShareDiluted_1_Q3_USD":0.05,"EarningsPerShareDiluted_3_Q3_USD":-0.16,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":28674000.0,"NetIncomeLoss_1_Q3_USD":2389000.0,"NetIncomeLoss_3_Q3_USD":-7605000.0,"StockholdersEquity_0_Q3_USD":319416000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":48281000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":46437000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":46241000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":46437000.0,"Ticker":"AMPH","CIK":"1297184","name":"AMPHASTAR PHARMACEUTICALS, INC.","OfficialName":"Amphastar Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905609900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181109"}]